Those diverse tumor inducers determine a limited sets of nuclear transcription factors, including Sp1, Stat3 and NF-κB [36], conferring a high survival and growth advantage to cancer cells through alteration of the expression and functions of downstream effector factors, such as VEGF and interleukin 8 (IL-8). The gene discussed is STAT3; the disease is neoplasm.